Evidence map›Paper›PMID 38053027›Full record

ArticleBMC infectious diseases2023

The diagnostic dilemma for atypical presentation of progressive human Mpox.

Syeda Sahra, Raul Orozco Villalobos, Brian M Scott, Deidra J Bowman, Joseph Sassine, Michelle Salvaggio, Douglas A Drevets, Nelson Iván Agudelo Higuita

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Rethinking mpox: epidemiology, clinical variants, diagnosis, and response.Osong public health and research perspectives · 2026
    Article
  3. Exploring the Resurgence of a Neglected Disease: Lessons From the 2023-2024 Mpox Outbreak in Rio de Janeiro, Brazil.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Syeda SahraSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA. syeda-sahra@ouhsc.edu.
Raul Orozco VillalobosDepartment of Internal Medcine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
Brian M ScottSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
Deidra J BowmanSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
Joseph SassineSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
Michelle SalvaggioSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
Douglas A DrevetsSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
Nelson Iván Agudelo HiguitaSection of Infectious Diseases, Department of Internal Medicine, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK, 73104, USA.
University of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman mpox has increasingly been reported worldwide since May 2022, with higher incidence in men who have sex with men (MSM) and persons living with HIV (PLHIV) with presentation typical for generalized macules and papules. CASE PRESENTATION: We are describing a case of human mpox, which presented as widespread, atypical round verrucous lesions that went undiagnosed in the community for six months and was treated with antibacterials and antifungals given the similarity to skin manifestations associated with endemic mycoses.

conclusionsSuspicion for human mpox should be high in young MSM and PLHIV who present with rash and mpox should be ruled out earlier.

Indexed as

Mpox, MonkeypoxSexual and Gender MinoritiesAnti-Bacterial AgentsAntifungal AgentsHomosexuality, MaleHumansMaleAnti-Bacterial AgentsAntifungal AgentsAtypical rashHuman MpoxMen who have sex with menPersons living with HIV

Identifiers

PMID38053027
PMCPMC10696784
OpenAlexW4389333369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.